This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pratt, J. S.
Right arrow Articles by Young, V. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pratt, J. S.
Right arrow Articles by Young, V. B.

 Previous Article  |  Next Article 

Infection and Immunity, August 2006, p. 4496-4504, Vol. 74, No. 8
0019-9567/06/$08.00+0     doi:10.1128/IAI.00503-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus

Jason S. Pratt,1,2 Kacey L. Sachen,1 Heather D. Wood,1 Kathryn A. Eaton,4,5 and Vincent B. Young1,2,3*

Department of Microbiology and Molecular Genetics,1 National Food Safety and Toxicology Center,2 Infectious Diseases Unit, Department of Internal Medicine, Michigan State University, East Lansing, Michigan 48824,3 Unit for Laboratory Animal Medicine,4 Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor, Michigan 481095

Received 28 March 2006/ Returned for modification 3 May 2006/ Accepted 11 May 2006

Persistent murine infection with Helicobacter hepaticus leads to chronic gastrointestinal inflammation and neoplasia in susceptible strains. To determine the role of the virulence factor cytolethal distending toxin (CDT) in the pathogenesis of this organism, interleukin-10-deficient (IL-10–/–) mice were experimentally infected with wild-type H. hepaticus and a CDT-deficient isogenic mutant. Both wild-type H. hepaticus and the CDT-deficient mutant successfully colonized IL-10–/– mice, and they reached similar tissue levels by 6 weeks after infection. Only animals infected with wild-type type H. hepaticus developed significant typhlocolitis. However, by 4 months after infection, the CDT-deficient mutant was no longer detectable in IL-10–/– mice, whereas wild-type H. hepaticus persisted for the 8-month duration of the experiment. Animals infected with wild-type H. hepaticus exhibited severe typhlocolitis at 8 months after infection, while animals originally challenged with the CDT-deficient mutant had minimal cecal inflammation at this time point. In follow-up experiments, animals that cleared infection with the CDT-deficient mutant were protected from rechallenge with either mutant or wild-type H. hepaticus. Animals infected with wild-type H. hepaticus developed serum immunoglobulin G1 (IgG1) and IgG2c responses against H. hepaticus, while animals challenged with the CDT-deficient mutant developed significantly lower IgG2c responses and failed to mount IgG1 responses against H. hepaticus. These results suggest that CDT plays a key immunomodulatory role that allows persistence of H. hepaticus and that in IL-10–/– mice this alteration of the host immune response results in the development of colitis.

* Corresponding author. Mailing address: Room B42, Food Safety and Toxicology Building, Michigan State University, East Lansing, MI 48824. Phone: (517) 432-3100. Fax: (517) 432-2310. E-mail: youngvi{at}msu.edu.

Editor: J. T. Barbieri

Infection and Immunity, August 2006, p. 4496-4504, Vol. 74, No. 8
0019-9567/06/$08.00+0     doi:10.1128/IAI.00503-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shen, Z., Feng, Y., Rogers, A. B., Rickman, B., Whary, M. T., Xu, S., Clapp, K. M., Boutin, S. R., Fox, J. G. (2009). Cytolethal Distending Toxin Promotes Helicobacter cinaedi-Associated Typhlocolitis in Interleukin-10-Deficient Mice. Infect. Immun. 77: 2508-2516 [Abstract] [Full Text]  
  • Varon, C, Duriez, A, Lehours, P, Menard, A, Laye, S, Zerbib, F, Megraud, F, Laharie, D (2009). Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 58: 629-635 [Abstract] [Full Text]  
  • Harris, L., Senagore, P., Young, V. B., McCabe, L. R. (2009). Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1020-G1029 [Abstract] [Full Text]  
  • Toth, I., Nougayrede, J.-P., Dobrindt, U., Ledger, T. N., Boury, M., Morabito, S., Fujiwara, T., Sugai, M., Hacker, J., Oswald, E. (2009). Cytolethal Distending Toxin Type I and Type IV Genes Are Framed with Lambdoid Prophage Genes in Extraintestinal Pathogenic Escherichia coli. Infect. Immun. 77: 492-500 [Abstract] [Full Text]  
  • Degnan, P. H., Moran, N. A. (2008). Diverse Phage-Encoded Toxins in a Protective Insect Endosymbiont. Appl. Environ. Microbiol. 74: 6782-6791 [Abstract] [Full Text]  
  • Alyamani, E. J., Brandt, P., Pena, J. A., Major, A. M., Fox, J. G., Suerbaum, S., Versalovic, J. (2007). Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology 153: 1006-1016 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»